Health Care Contracts & Agreements
155,127 Contracts from 2,089 Health Care Companies
- Biotechnology (58,378 contracts from 663 companies)
- Health Care Equipment & Supplies (28,642 | 356)
- Health Care Providers & Services (25,775 | 473)
- Health Care Technology (4,868 | 71)
- Life Sciences Tools & Services (5,042 | 64)
- Pharmaceuticals (32,422 | 462)
- License, Development and Commercialization Agreement, by and between the Company and Lees Pharmaceutical (HK) Ltd., dated January 12, 2024 (WINDTREE THERAPEUTICS INC, Filed With SEC on April 16, 2024)
- Amendment No. 1, effective as of January 17, 2024, to the License Agreement, between Windtree and Philip Morris Products S.A. dated March 28, 2008 (WINDTREE THERAPEUTICS INC, Filed With SEC on April 16, 2024)
- Amendment No. 1, effective as of January 17, 2024, to the Amended and Restated License Agreement, between Windtree and Philip Morris USA Inc. dated March 28, 2008 (WINDTREE THERAPEUTICS INC, Filed With SEC on April 16, 2024)
- RespireRx-Dariusz Nasiek and Sara Nasiek, JTTEN Warrant dated April 10, 2024 (RespireRx Pharmaceuticals Inc., Filed With SEC on April 16, 2024)
- RespireRx-Dariusz Nasiek and Sara Nasiek, JTTEN Demand Promissory Note dated April 10, 2024 (RespireRx Pharmaceuticals Inc., Filed With SEC on April 16, 2024)
- RespireRx Demand Promissory Note and Warrant Purchase Agreement with Dariusz Nasiek and Sara Nasiek dated April 10, 2024 (RespireRx Pharmaceuticals Inc., Filed With SEC on April 16, 2024)
- Amendment to Consulting Agreement with F. Diaz-Mitoma Professional Corporation, effective January 1, 2024 (VBI Vaccines Inc, Filed With SEC on April 16, 2024)
- Extension to Forbearance Agreement, dated February 6, 2024, by and among VBI Vaccines Inc., Variation Biotechnologies Inc. and K2 HealthVentures LLC (VBI Vaccines Inc, Filed With SEC on April 16, 2024)
- Extension to Forbearance Agreement, dated January 23, 2024, by and among VBI Vaccines Inc., Variation Biotechnologies Inc. and K2 HealthVentures LLC (VBI Vaccines Inc, Filed With SEC on April 16, 2024)
- Extension to Forbearance Agreement, dated January 9, 2024, by and among VBI Vaccines Inc., Variation Biotechnologies Inc. and K2 HealthVentures LLC (VBI Vaccines Inc, Filed With SEC on April 16, 2024)
- Extension to Forbearance Agreement, dated December 26, 2023, by and among VBI Vaccines Inc., Variation Biotechnologies Inc. and K2 HealthVentures LLC (VBI Vaccines Inc, Filed With SEC on April 16, 2024)
- Extension to Forbearance Agreement, dated December 12, 2023, by and among VBI Vaccines Inc., Variation Biotechnologies Inc. and K2 HealthVentures LLC (VBI Vaccines Inc, Filed With SEC on April 16, 2024)
- Extension to Forbearance Agreement, dated November 28, 2023, by and among VBI Vaccines Inc., Variation Biotechnologies Inc. and K2 HealthVentures LLC (VBI Vaccines Inc, Filed With SEC on April 16, 2024)
- Rodrigues Employment Agreement, dated April 16, 2024, between the Company and Dominic Rodrigues (PROVECTUS BIOPHARMACEUTICALS, INC., Filed With SEC on April 16, 2024)
- Pershing Employment Agreement, dated April 16, 2024, between the Company and Ed Pershing (PROVECTUS BIOPHARMACEUTICALS, INC., Filed With SEC on April 16, 2024)
- Form of Pre-Funded Warrant (Cullinan Oncology, LLC, Filed With SEC on April 16, 2024)
- Form of Registration Rights Agreement, dated April 15, 2024, by and among Cullinan Therapeutics, Inc. and the purchasers party thereto (Cullinan Oncology, LLC, Filed With SEC on April 16, 2024)
- Form of Stock Purchase Agreement, dated April 15, 2024, by and among Cullinan Therapeutics, Inc. and the purchasers party thereto (Cullinan Oncology, LLC, Filed With SEC on April 16, 2024)
- Security and Pledge Agreement dated as of April 12, 2024 made by Theralink Technologies, Inc. and each of its subsidiaries party thereto as Grantors, in favor of IMAC Holdings, Inc (IMAC Holdings, Inc., Filed With SEC on April 16, 2024)
- Credit Agreement dated as of April 11, 2024 between IMAC Holdings, Inc. and Theralink Technologies, Inc (IMAC Holdings, Inc., Filed With SEC on April 16, 2024)
- Form of Settlement and Release Agreement dated as of April 10, 2024 with schedule of signatories (IMAC Holdings, Inc., Filed With SEC on April 16, 2024)
- Registration Rights Agreement dated as of April 10, 2024, by and among IMAC Holdings, Inc. and the Investors signatory thereto (IMAC Holdings, Inc., Filed With SEC on April 16, 2024)
- Securities Purchase Agreement dated as of April 10, 2024, by and among IMAC Holdings, Inc. and the Investors signatory thereto (IMAC Holdings, Inc., Filed With SEC on April 16, 2024)
- Form of Exchange Agreement dated as of April 10, 2024 with schedule of signatories (IMAC Holdings, Inc., Filed With SEC on April 16, 2024)
- Form of Placement Agent Warrant (IMAC Holdings, Inc., Filed With SEC on April 16, 2024)
- Form of PIPE Warrant (IMAC Holdings, Inc., Filed With SEC on April 16, 2024)
- Form of Exchange Warrant (IMAC Holdings, Inc., Filed With SEC on April 16, 2024)
- Lease Agreement for Suite 510, dated January 1, 2024, between Insight Genetics, Inc. and MPC Holdings, LLC (OncoCyte Corp, Filed With SEC on April 16, 2024)
- Lease Agreement for Suite 410, dated January 1, 2024, between Insight Genetics, Inc. and MPC Holdings, LLC (OncoCyte Corp, Filed With SEC on April 16, 2024)
- Lease Agreement for Suite 103, dated January 1, 2024, between Insight Genetics, Inc. and MPC Holdings, LLC (OncoCyte Corp, Filed With SEC on April 16, 2024)
- (Salona Global Medical Device Corp, Filed With SEC on April 16, 2024)
- Settlement Agreement between Immune Therapeutics, Inc. and Jack Brewer dated October 23, 2022 (Immune Therapeutics, Inc., Filed With SEC on April 16, 2024)
- First Amendment to Promissory Note between Immune Therapeutics, Inc. and Ira Gaines dated November 4, 2022 (Immune Therapeutics, Inc., Filed With SEC on April 16, 2024)
- Promissory Note dated April 10, 2024 between the Company and the Lender (PetVivo Holdings, Inc., Filed With SEC on April 16, 2024)
- Common Stock Purchase Warrant dated April 12, 2024, issued by us to Yi Hua Chen (RITTER PHARMACEUTICALS INC, Filed With SEC on April 16, 2024)
- 8% Convertible Debenture dated April 12, 2024, issued by us to Yi Hua Chen (RITTER PHARMACEUTICALS INC, Filed With SEC on April 16, 2024)
- Description of Capital Stock (INVO Bioscience, Inc., Filed With SEC on April 16, 2024)
- Second Amendment to the Exclusive License Agreement by and between the Registrant and The Washington University, dated as of November 28, 2023 (HISTOGENICS CORP, Filed With SEC on April 16, 2024)
- Confidential Information, Invention Assignment, Non-Competition, and Arbitration Agreement, dated March 24, 2024, between CareDx, Inc. and John Hanna (CareDx, Inc., Filed With SEC on April 16, 2024)
- Change of Control and Severance Agreement, dated March 25, 2024, between CareDx, Inc. and John Hanna (CareDx, Inc., Filed With SEC on April 16, 2024)
